Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.

Zhengnan HuangYilin YanTengjiao WangZeyi WangJinming CaiXiangqian CaoChenkai YangFang ZhangGang WuBing Shen

Published in: Journal of translational medicine (2022)

Taken together, our results indicated that ENO1 might serve as a promising prognostic biomarker for prognosticating prognosis associated with the tumor immune microenvironment, suggesting that ENO1 could be a potential immune-related target against BLCA.

Keyphrases

stem cells
endothelial cells
nitric oxide synthase
pi k akt
nitric oxide
risk assessment
climate change
bioinformatics analysis
drug induced